Submit Deal

ONESOURCE SPECIALTY PHARMA

Summary

OneSource Specialty Pharma Limited, formerly known as Stelis Biopharma Limited, is India's first specialty pharma pure-play CDMO business.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 76 M

Avg. Deal Size£ 76 M

Market Context

Senior Management

Sort

Target: ONESOURCE SPECIALTY PHARMA

Bidder: WHITE OAK INVESTMENT MANAGEMENT PRIVATE LIMITED

2 Service Providers

4 Dealmakers

£ 75 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy